These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35294075)

  • 1. Brain oxygen extraction and neural tissue susceptibility are associated with cognitive impairment in older individuals.
    Chiang GC; Cho J; Dyke J; Zhang H; Zhang Q; Tokov M; Nguyen T; Kovanlikaya I; Amoashiy M; de Leon M; Wang Y
    J Neuroimaging; 2022 Jul; 32(4):697-709. PubMed ID: 35294075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Oxygen Extraction Is Differentially Altered by Alzheimer's and Vascular Diseases.
    Jiang D; Lin Z; Liu P; Sur S; Xu C; Hazel K; Pottanat G; Darrow J; Pillai JJ; Yasar S; Rosenberg P; Moghekar A; Albert M; Lu H
    J Magn Reson Imaging; 2020 Dec; 52(6):1829-1837. PubMed ID: 32567195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal changes in brain oxygen extraction fraction (OEF) in older adults: Relationship to markers of vascular and Alzheimer's pathology.
    Lin Z; Lim C; Jiang D; Soldan A; Pettigrew C; Oishi K; Zhu Y; Moghekar A; Liu P; Albert M; Lu H
    Alzheimers Dement; 2023 Feb; 19(2):569-577. PubMed ID: 35791732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
    Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
    Front Immunol; 2021; 12():803504. PubMed ID: 34956241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
    Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A;
    J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen Metabolic Stress and White Matter Injury in Patients With Cerebral Small Vessel Disease.
    Kang P; Ying C; Chen Y; Ford AL; An H; Lee JM
    Stroke; 2022 May; 53(5):1570-1579. PubMed ID: 34886686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain oxygen extraction fraction mapping in patients with multiple sclerosis.
    Cho J; Nguyen TD; Huang W; Sweeney EM; Luo X; Kovanlikaya I; Zhang S; Gillen KM; Spincemaille P; Gupta A; Gauthier SA; Wang Y
    J Cereb Blood Flow Metab; 2022 Feb; 42(2):338-348. PubMed ID: 34558996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
    Arfanakis K; Evia AM; Leurgans SE; Cardoso LFC; Kulkarni A; Alqam N; Lopes LF; Vieira D; Bennett DA; Schneider JA
    J Alzheimers Dis; 2020; 73(1):333-345. PubMed ID: 31771057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White Matter Hyperintensities and Cognitive Impairment in Healthy and Pathological Aging: A Quantified Brain MRI Study.
    Kaskikallio A; Karrasch M; Koikkalainen J; Lötjönen J; Rinne JO; Tuokkola T; Parkkola R; Grönholm-Nyman P
    Dement Geriatr Cogn Disord; 2019; 48(5-6):297-307. PubMed ID: 32209796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensity load varies depending on subjective cognitive decline criteria.
    Morrison C; Dadar M; Villeneuve S; Ducharme S; Collins DL
    Geroscience; 2023 Feb; 45(1):17-28. PubMed ID: 36401741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracting and summarizing white matter hyperintensities using supervised segmentation methods in Alzheimer's disease risk and aging studies.
    Ithapu V; Singh V; Lindner C; Austin BP; Hinrichs C; Carlsson CM; Bendlin BB; Johnson SC
    Hum Brain Mapp; 2014 Aug; 35(8):4219-35. PubMed ID: 24510744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer's disease that emerge prior to dementia.
    Schoemaker D; Zanon Zotin MC; Chen K; Igwe KC; Vila-Castelar C; Martinez J; Baena A; Fox-Fuller JT; Lopera F; Reiman EM; Brickman AM; Quiroz YT
    Alzheimers Res Ther; 2022 Jun; 14(1):89. PubMed ID: 35768838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
    Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
    Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
    Soldan A; Pettigrew C; Zhu Y; Wang MC; Moghekar A; Gottesman RF; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M;
    Neurology; 2020 Mar; 94(9):e950-e960. PubMed ID: 31888969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
    Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
    Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment.
    Arvanitakis Z; Fleischman DA; Arfanakis K; Leurgans SE; Barnes LL; Bennett DA
    Brain Struct Funct; 2016 May; 221(4):2135-46. PubMed ID: 25833685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.